C. Henke

发表

Practice Variation in Rheumatologists' Encounters With Their Patients Who Have Rheumatoid Arthritis

W. Epstein, C. Henke, 1991, Medical care.

Medical costs, Medicaid, and managed mental health treatment: the Hawaii study.

M. Pallak, N. Cummings, H. Dörken, 1994, Managed care quarterly.

Effect of parenterally administered gold therapy on the course of adult rheumatoid arthritis.

E. Yelin, W. Epstein, P. Katz, 1991, Annals of internal medicine.

What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?

L. Criswell, C. Henke, 1995, The Journal of rheumatology.

Costs of acid-related disorders to a health maintenance organization.

J. Selby, T. Levin, J. Henning, 1997, American Journal of Medicine.

Somatization, psychiatric disorder, and stress in utilization of ambulatory medical services.

E. Perez-stable, R. Muñoz, W. Hargreaves, 1991, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

HMO membership, treatment, and mortality risk among prostatic cancer patients.

H. Greenwald, C. Henke, H P Greenwald, 1992, American journal of public health.

Functional status and somatization as predictors of medical offset in anxious and depressed patients.

D. Patrick, W. Schonfeld, C. Henke, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Switching the Histamine H2 Receptor Antagonist Famotidine to Nonprescription Status in Canada

B. O'brien, R. Goeree, C. Henke, 2012, PharmacoEconomics.

Managed mental health, Medicaid, and medical cost offset.

M. Pallak, N. Cummings, H. Dörken, 1993, New directions for mental health services.

The nature of U.S. rheumatology practice, 1977.

W. Epstein, C. Henke, 1981, Arthritis and rheumatism.

An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia.

B. Parasuraman, R. R. Williams, B. Rittenhouse, 2000, The American journal of managed care.

A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.

J. L. Taylor, P. Keck, J. Bennett, 1996, The Journal of clinical psychiatry.

A cost-effectiveness and cost-benefit analysis of contingency contracting-enhanced methadone detoxification treatment.

S. Hall, K. Delucchi, D. Tusel, 1999, The American journal of drug and alcohol abuse.

Cost of Treatment for Onychomycosis

J. Schein, J. Broering, W. Schonfeld, 2012, PharmacoEconomics.

Cost of treatment for onychomycosis. Data from a 9-month observational study.

J. Broering, W. Schonfeld, D. Stier, 2001, PharmacoEconomics.

Correlates of Fatigue in Older Adults with Rheumatoid Arthritis

B. Belza, E. Yelin, W. Epstein, 1993, Nursing research.

The training of United States rheumatologists, 1927-1976. Description and evaluation of the training experience.

W. Epstein, C. Henke, 1979, Arthritis and rheumatism.

Polypharmacy among patients attending an AIDS clinic: utilization of prescribed, unorthodox, and investigational treatments.

R. Greenblatt, H. Hollander, C. Henke, 1991, Journal of acquired immune deficiency syndromes.

The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs.

D. L. Curtis, E. Yelin, W. Epstein, 1978, Arthritis and rheumatism.

Study of internal medicine.

W. Epstein, C. Henke, 1979, Annals of internal medicine.

A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practices.

M. Nevitt, E. Yelin, W. Epstein, 1985, The New England journal of medicine.

A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization

J. Selby, T. Levin, J. Henning, 1998, American Journal of Gastroenterology.

Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database.

P. Carroll, D. Penson, M. Litwin, 2001, Urology.

Work disability among persons with musculoskeletal conditions.

E. Yelin, W. Epstein, C. Henke, 1986, Arthritis and rheumatism.

Methotrexate for juvenile rheumatoid arthritis.

L. Criswell, W. Epstein, C. Henke, 1992, The New England journal of medicine.

The economic impact of the tacrine in the treatment of Alzheimer's disease.

M. Burchmore, C. Henke, 1997, Clinical therapeutics.

Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a Health Maintenance Organization

T. Levin, J. Henning, C. Henke, 2000, American Journal of Gastroenterology.

First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary.

B. O'brien, B. Winblad, M. Sano, 1998, Alzheimer disease and associated disorders.

Risk factors for hospitalization and surgery in patients with rheumatoid arthritis: implications for capitated medical payment.

M. Nevitt, E. Yelin, W. Epstein, 1986, Annals of internal medicine.

The work dynamics of the person with rheumatoid arthritis.

E. Yelin, W. Epstein, E Yelin, 1987, Arthritis and rheumatism.

Resources for the care of arthritics in a nonmetropolitan community. Redding, California.

E. Yelin, W. Epstein, C. Henke, 1977, Arthritis and rheumatism.

The university rheumatic disease clinic

E. Yelin, W. Epstein, C. Henke, 1977 .

An economic evaluation of a chlorhexidine chip for treating chronic periodontitis: the CHIP (chlorhexidine in periodontitis) study.

L. Wolff, R. Genco, G. Armitage, 2001, Journal of the American Dental Association.